These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 11420687)
1. Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance. Friedrich K; Wieder T; Von Haefen C; Radetzki S; Jänicke R; Schulze-Osthoff K; Dörken B; Daniel PT Oncogene; 2001 May; 20(22):2749-60. PubMed ID: 11420687 [TBL] [Abstract][Full Text] [Related]
2. The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines. Radetzki S; Köhne CH; von Haefen C; Gillissen B; Sturm I; Dörken B; Daniel PT Oncogene; 2002 Jan; 21(2):227-38. PubMed ID: 11803466 [TBL] [Abstract][Full Text] [Related]
3. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Blanc C; Deveraux QL; Krajewski S; Jänicke RU; Porter AG; Reed JC; Jaggi R; Marti A Cancer Res; 2000 Aug; 60(16):4386-90. PubMed ID: 10969782 [TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy-induced death of MCF-7 human breast cancer cells: a role for caspase-3 in the late steps of apoptosis but not for the critical lethal event. Xue LY; Chiu SM; Oleinick NL Exp Cell Res; 2001 Feb; 263(1):145-55. PubMed ID: 11161713 [TBL] [Abstract][Full Text] [Related]
5. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells. Jänicke RU; Engels IH; Dunkern T; Kaina B; Schulze-Osthoff K; Porter AG Oncogene; 2001 Aug; 20(36):5043-53. PubMed ID: 11526489 [TBL] [Abstract][Full Text] [Related]
6. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways. Park SJ; Wu CH; Safa AR Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586 [TBL] [Abstract][Full Text] [Related]
7. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Yang XH; Sladek TL; Liu X; Butler BR; Froelich CJ; Thor AD Cancer Res; 2001 Jan; 61(1):348-54. PubMed ID: 11196185 [TBL] [Abstract][Full Text] [Related]
8. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line. Wu GS; Ding Z Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171 [TBL] [Abstract][Full Text] [Related]
9. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Kazhdan I; Marciniak RA Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201 [TBL] [Abstract][Full Text] [Related]
10. Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis. Chen JS; Konopleva M; Andreeff M; Multani AS; Pathak S; Mehta K J Cell Physiol; 2004 Aug; 200(2):223-34. PubMed ID: 15174092 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy. Végran F; Boidot R; Oudin C; Riedinger JM; Bonnetain F; Lizard-Nacol S Clin Cancer Res; 2006 Oct; 12(19):5794-800. PubMed ID: 17020986 [TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135 [TBL] [Abstract][Full Text] [Related]
13. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels. Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839 [TBL] [Abstract][Full Text] [Related]
14. Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells. von Haefen C; Wieder T; Gillissen B; Stärck L; Graupner V; Dörken B; Daniel PT Oncogene; 2002 Jun; 21(25):4009-19. PubMed ID: 12037683 [TBL] [Abstract][Full Text] [Related]
15. [Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells]. Sun YL; Zhou GY; Li KN; Li WT; Song XR; Gao P Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):518-21. PubMed ID: 15949329 [TBL] [Abstract][Full Text] [Related]
16. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810 [TBL] [Abstract][Full Text] [Related]
18. A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers. Seth P; Katayose D; Li Z; Kim M; Wersto R; Craig C; Shanmugam N; Ohri E; Mudahar B; Rakkar AN; Kodali P; Cowan K Cancer Gene Ther; 1997; 4(6):383-90. PubMed ID: 9408609 [TBL] [Abstract][Full Text] [Related]
19. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Brenes O; Arce F; Gätjens-Boniche O; Díaz C Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942 [TBL] [Abstract][Full Text] [Related]
20. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells. Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]